PDBsum entry 5eap

Transcription/transcription inhibitor

PDB id: 5eap

Contents

Protein chain

310 a.a.

Ligands

5MO

GOL

EDO ×5

UNX ×14

Metals

_CL

Waters ×101

References listed in PDB file

Key reference

• Title: Structure-Based optimization of a small molecule antagonist of the interaction between wd repeat-Containing protein 5 (wdr5) and mixed-Lineage leukemia 1 (mll1).
• Authors: M.Getlik, D.Smil, C.Zepeda-Velázquez, Y.Bolshan, G.Poda, H.Wu, A.Dong, E.Kuznetsova, R.Marcellus, G.Senisterra, L.Dombrovski, T.Hajian, T.Kiyota, M.Schapira, C.H.Arrowsmith, P.J.Brown, M.Vedadi, R.Al-Awar.
• Ref.: J Med Chem, 2016, 59, 2478-2496. [DOI no: 10.1021/acs.jmedchem.5b01630]
• PubMed id: 26958703

Abstract

WD repeat-containing protein 5 (WDR5) is an important component of the multiprotein complex essential for activating mixed-lineage leukemia 1 (MLL1). Rearrangement of the MLL1 gene is associated with onset and progression of acute myeloid and lymphoblastic leukemias, and targeting the WDR5-MLL1 interaction may result in new cancer therapeutics. Our previous work showed that binding of small molecule ligands to WDR5 can modulate its interaction with MLL1, suppressing MLL1 methyltransferase activity. Initial structure-activity relationship studies identified N-(2-(4-methylpiperazin-1-yl)-5-substituted-phenyl) benzamides as potent and selective antagonists of this protein-protein interaction. Guided by crystal structure data and supported by in silico library design, we optimized the scaffold by varying the C-1 benzamide and C-5 substituents. This allowed us to develop the first highly potent (Kdisp < 100 nM) small molecule antagonists of the WDR5-MLL1 interaction and demonstrate that N-(4-(4-methylpiperazin-1-yl)-3'-(morpholinomethyl)-[1,1'-biphenyl]-3-yl)-6-oxo-4-(trifluoromethyl)-1,6-dihydropyridine-3-carboxamide 16d (OICR-9429) is a potent and selective chemical probe suitable to help dissect the biological role of WDR5.